HNHendrik Nolte
Hendrik Nolte
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hendrik Nolte has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
Amarjot Kaur
Research and Development, Merck & Co., Inc., Kenilworth, NJ
10 shared publicationsDavid I. Bernstein
Bernstein Clinical Research Center and University of Cincinnati, Cincinnati, Ohio
7 shared publicationsJennifer Maloney
Merck & Co, Inc, Kenilworth, NJ
7 shared publicationsHarold S. Nelson
Department of Medicine, National Jewish Health, Denver, Colo
6 shared publicationsZiliang Li
Merck & Co, Kenilworth, NJ
5 shared publicationsGary Berman
Clinical Research Institute, Inc, Minneapolis, Minn
4 shared publications
Latest Publications
- 1 January 2017
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 5 (1) , 84-89.e3
Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets
- 1 January 2017
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 5 (1) , 84-89.e3
Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets
- 1 December 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 117 (6) , 690-696.e1
Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial
- 1 December 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 117 (6) , 690-696.e1
Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial
- 1 December 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (6) , 1631-1638
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial
- 1 December 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (6) , 1631-1638
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial
- 1 November 2016
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 4 (6) , 1194-1204.e4
Coseasonal Initiation of Allergen Immunotherapy: A Systematic Review
- 1 November 2016
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 4 (6) , 1194-1204.e4
Coseasonal Initiation of Allergen Immunotherapy: A Systematic Review
- Open Access
- 1 October 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (4) , 1081-1088.e4
Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses
- 1 October 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (4) , 1081-1088.e4
Open AccessTreatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses
- 1 September 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 117 (3) , 298-303
Major allergen content consistency of SQ house dust mite sublingual immunotherapy tablets and relevance across geographic regions
- 1 September 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 117 (3) , 298-303
Major allergen content consistency of SQ house dust mite sublingual immunotherapy tablets and relevance across geographic regions
- Open Access
- 1 March 2016
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 4 (2) , 301-309.e2
Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated
- 1 March 2016
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 4 (2) , 301-309.e2
Open AccessSequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated
- 1 January 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 116 (1) , 59-65
Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites
- 1 January 2016
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 116 (1) , 59-65
Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites
- 1 December 2015
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 115 (6) , 509-515.e2
Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet
- 1 December 2015
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 115 (6) , 509-515.e2
Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet
- 1 June 2015
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 135 (6) , 1494-1501.e6
Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber
- 1 June 2015
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 135 (6) , 1494-1501.e6
Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber